Information Journal Paper
APA:
CopyEMBIL, J.M., PAPP, K., & SIBBALD, G.. (2000). RECOMBINANT HUMAN PLATELET-DERIVED GROWTH FACTOR-BB (BECAPLERMIN) FOR HEALING CHRONIC LOWER EXTREMITY DIABETIC ULCERS: AN OPEN-LABEL CLINICAL EVALUATION OF EFFICACY. WOUND REPAIR AND REGENERATION, 8(-), 162-168. SID. https://sid.ir/paper/657275/en
Vancouver:
CopyEMBIL J.M., PAPP K., SIBBALD G.. RECOMBINANT HUMAN PLATELET-DERIVED GROWTH FACTOR-BB (BECAPLERMIN) FOR HEALING CHRONIC LOWER EXTREMITY DIABETIC ULCERS: AN OPEN-LABEL CLINICAL EVALUATION OF EFFICACY. WOUND REPAIR AND REGENERATION[Internet]. 2000;8(-):162-168. Available from: https://sid.ir/paper/657275/en
IEEE:
CopyJ.M. EMBIL, K. PAPP, and G. SIBBALD, “RECOMBINANT HUMAN PLATELET-DERIVED GROWTH FACTOR-BB (BECAPLERMIN) FOR HEALING CHRONIC LOWER EXTREMITY DIABETIC ULCERS: AN OPEN-LABEL CLINICAL EVALUATION OF EFFICACY,” WOUND REPAIR AND REGENERATION, vol. 8, no. -, pp. 162–168, 2000, [Online]. Available: https://sid.ir/paper/657275/en